Researchers at the
The nanoemulsions carry antibodies and protein and can generate an immune response against infectious diseases such as influenza, HIV and malaria.
A paper on the development has been published in the international journal SMALL
He said it addressed challenges with existing targeted therapies, such as limited drug-carrying capacity and difficulty of manufacture.
An ability to target specific cells gives the emulsion the potential to overcome side-effects of broad-spectrum treatments such as chemotherapy, which attacks healthy cells as well as cancerous ones.
Dr Sainsbury said the nanoemulsion could hold antibodies, releasing them only when targeted cells were found.
"This is about efficient targeting," he said.
"Nanoemulsions have a long, safe history in pharmaceutical formulations.
The research is a collaboration between Professor
CC AutoTriage1pm-140125-30TagarumaMar-4613958 30TagarumaMar
Most Popular Stories
- Chobani Counters Competition With Expanded Lineup
- Pope Francis, Huge Crowd Joyously Celebrate Easter
- Automakers Turn to China to Fuel Sales Growth
- NASA's Space Station Robonaut Finally Getting Legs
- Ohio Couple Married 70 Years, Die 15 Hours Apart
- Report: Iran VP Says Row Over Reactor Resolved
- Confusion, Anger as Sunken Ferry's Relatives Wait
- Iran Denounces U.S. Ruling to Sell Property
- GOP Making Bold Play for Oregon Senate Seat
- Putin: No Blocks to Boosting Relations With West